Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syngen Biotech Co Ltd, Te-Sheng ChangfiledCriticalSyngen Biotech Co Ltd
Priority to TW95112052ApriorityCriticalpatent/TWI312686B/en
Publication of TW200738274ApublicationCriticalpatent/TW200738274A/en
Application grantedgrantedCritical
Publication of TWI312686BpublicationCriticalpatent/TWI312686B/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Pyrane Compounds
(AREA)
Abstract
The present invention concerns 6,7,4'-trihydroxyisoflavone, 7,8,4'-trihrdroxyisoflavone, and 5,7,8,4'-tetrahrdroxyisoflavone useful as a potent tyrosinase inhibitor. The compounds of the present invention are commercial available. They may be used to inhibit tyrosinase activity in the skin melanocyte. Hence, these compounds could be used as an excellent skin-whitening agent and could prevent melanin synthesis of human skin.
TW95112052A2006-04-042006-04-04Inhibitors for the melanin formation of skin
TWI312686B
(en)